Clinical Trial Update: A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of vaniprevir with pegylated interferon and ribavirin in Japanese participants with chronic hepatitis C; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• vaniprevir (vaniprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-09-29